These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1526688)
21. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose. Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days. Frías J; Esteban C; Carcas AJ; Sánchez-García P; Albet C; Torres J; Márquez M; Ortiz JA Arzneimittelforschung; 1997 Apr; 47(4A):531-4. PubMed ID: 9205759 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia. Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339 [TBL] [Abstract][Full Text] [Related]
25. Investigation of the pharmacokinetic behavior of barucainide in man during an early phase I study. Brode E; Müller-Peltzer H; Indest H Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):717-24. PubMed ID: 1294860 [TBL] [Abstract][Full Text] [Related]
26. Determination of cicletanine enantiomers in plasma by high-performance capillary electrophoresis. Pruñonosa J; Obach R; Diez-Cascón A; Gouesclou L J Chromatogr; 1992 Feb; 574(1):127-33. PubMed ID: 1629275 [TBL] [Abstract][Full Text] [Related]
27. Population-based meta-analysis of hydrochlorothiazide pharmacokinetics. Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE Biopharm Drug Dispos; 2013 Dec; 34(9):527-39. PubMed ID: 24123104 [TBL] [Abstract][Full Text] [Related]
28. Effect of cicletanine on renal cGMP production. Valdivielso JM; Morales AI; Pérez-Barriocanal F; López-Novoa JM Can J Physiol Pharmacol; 1998 Dec; 76(12):1151-5. PubMed ID: 10326838 [TBL] [Abstract][Full Text] [Related]
29. Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids. Ferry N; Geoffroy J; Pozet N; Cuisinaud G; Benzoni D; Zech PY; Sassard J Br J Clin Pharmacol; 1988 Mar; 25(3):359-66. PubMed ID: 3358898 [TBL] [Abstract][Full Text] [Related]
30. Effects of cicletanine on the urinary excretion of prostanoids and kallikrein, and on renal function in man. Tsunoda K; Abe K; Omata K; Hagino T; Minami N; Munakata M; Yoshida K; Sakuma H; Misawa S; Arima S Cardiovasc Drugs Ther; 1993 Apr; 7(2):253-6. PubMed ID: 8357779 [TBL] [Abstract][Full Text] [Related]
31. Comparison of high-performance liquid chromatography and high-performance capillary electrophoresis for the determination of cicletanine in plasma. Pruñonosa J; Obach R; Diez-Cascón A; Gouesclou L J Chromatogr; 1992 Oct; 581(2):219-26. PubMed ID: 1452612 [TBL] [Abstract][Full Text] [Related]
33. Stereoselective biotransformation of cicletanine in cultured rat and human hepatocytes. Menard C; Lamiable D; Vistelle R; Morin E; Ratanasavanh D Pharmacol Res; 2000 Jul; 42(1):87-92. PubMed ID: 10860640 [TBL] [Abstract][Full Text] [Related]
34. A drug interaction study between cicletanine and tolbutamide in healthy volunteers. Bayés MC; Barbanoj MJ; Vallès J; Torrent J; Obach R; Jané F Eur J Clin Pharmacol; 1996; 50(5):381-4. PubMed ID: 8839660 [TBL] [Abstract][Full Text] [Related]
35. Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat. Garay RP; Rosati C; Fanous K; Allard M; Morin E; Lamiable D; Vistelle R Eur J Pharmacol; 1995 Feb; 274(1-3):175-80. PubMed ID: 7768271 [TBL] [Abstract][Full Text] [Related]
36. The pharmacokinetics of bumetanide in the newborn infant. Lopez-Samblas AM; Adams JA; Goldberg RN; Modi MW Biol Neonate; 1997; 72(5):265-72. PubMed ID: 9395836 [TBL] [Abstract][Full Text] [Related]
37. Arterial and venous blood sampling in pharmacokinetic studies: azosemide in rabbits. Lee SH; Shin WG; Lee MG; Kim ND Biopharm Drug Dispos; 1994 May; 15(4):305-16. PubMed ID: 8068868 [TBL] [Abstract][Full Text] [Related]
38. Determination of cicletanine in human plasma by high-performance liquid chromatography using automated column switching. Antoniewicz SM; Cook JA; Brown RR J Chromatogr; 1992 Jan; 573(1):93-8. PubMed ID: 1564111 [TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetic and metabolic study of disopyramide in oral and intravenous administration]. De Graeve J; Kremers P; Gielen JE Therapie; 1977; 32(2):195-204. PubMed ID: 898127 [No Abstract] [Full Text] [Related]
40. Effects of high altitude exposure on the pharmacokinetics of furosemide in healthy volunteers. Arancibia A; Nella Gai M; Paulos C; Chávez J; Pinilla E; Angel N; Ritschel WA Int J Clin Pharmacol Ther; 2004 Jun; 42(6):314-20. PubMed ID: 15222723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]